Prelude Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning, everyone, and welcome to the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma names here at the firm. It's my pleasure to be hosting Prelude Therapeutics in a fireside chat this morning. And with that, let me welcome the company. We've got company's CEO, Kris Vaddi; CFO, Brian Piper; and Chief Business Officer -- I'm sorry, and Christopher Pierce, the company's Chief Business Officer.
So with that, good morning, gentlemen, welcome to the conference, and we look forward to many more years of your participation. With that, for those who are perhaps newer to the Prelude story and you are recently -- relatively recently IPOed company, perhaps there are some who are unfamiliar with the Prelude story. So with that, maybe, Kris, if I could turn it over to you. And if you could just tell us a little bit more about the company, kind of maybe a little bit of its history and what you feel are kind
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
